Yüklüyor......
Pharmacological targeting of PI3K isoforms as a therapeutic strategy in chronic lymphocytic leukaemia
PI3Kδ inhibitors such as idelalisib are providing improved therapeutic options for the treatment of chronic lymphocytic leukaemia (CLL). However under certain conditions, inhibition of a single PI3K isoform can be compensated by the other PI3K isoforms, therefore PI3K inhibitors which target multipl...
Kaydedildi:
| Yayımlandı: | Leuk Res Rep |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588368/ https://ncbi.nlm.nih.gov/pubmed/26500849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2015.09.001 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|